QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis
QiangGuYin (QGY) is a common Traditional Chinese medicine prescription for the treatment of osteoporosis. Previous clinical studies have found that QGY effectively improves bone mineral density (BMD) in postmenopausal women, but its underlying mechanism remains unclear. The osteoprotegerin (OPG)/rec...
Guardado en:
Autores principales: | Xuefei Li, Longkang Cui, Wenhua Chen, Yuan Fang, Gaobo Shen, Zhen Li, Bingbing Zhang, Lianguo Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c114a42fbf04e1ca074e689a5dda35e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vertebral osteomyelitis is characterised by increased RANK/OPG and RANKL/OPG expression ratios in vertebral bodies and intervertebral discs
por: S Lang, et al.
Publicado: (2021) -
Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development
por: Bożena Bruhn-Olszewska, et al.
Publicado: (2017) -
RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp
por: Daisuke Nishida, et al.
Publicado: (2021) -
Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway
por: Xu X, et al.
Publicado: (2020) -
The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis.
por: Maha Sabry, et al.
Publicado: (2021)